3,774
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Genomic epidemiology and characterisation of penicillin-sensitive Staphylococcus aureus isolates from invasive bloodstream infections in China: an increasing prevalence and higher diversity in genetic typing be revealed

, , , , , & ORCID Icon show all
Pages 326-336 | Received 16 Nov 2021, Accepted 05 Jan 2022, Published online: 21 Jan 2022

References

  • Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53–59. doi:10.1086/345476.
  • Naber CK. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis. 2009;48(Suppl 4):S231–S237. doi:10.1086/598189.
  • van Hal SJ, Jensen SO, Vaska VL, et al. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25:362–386. doi:10.1128/CMR.05022-11.
  • Bai AD, Showler A, Burry L, et al. Impact of Infectious Disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: Results from a large multicenter cohort study. Clin Infect Dis. 2015;60:1451–1461. DOI:10.1093/cid/civ120.
  • Stryjewski ME, Szczech LA, Benjamin DK, Jr., et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007. 44. 190-196. doi:10.1086/510386
  • Kim SH, Kim KH, Kim HB, et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008;52:192–197. DOI:10.1128/aac.00700-07.
  • González C, Rubio M, Romero-Vivas J, et al. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999;29:1171–1177. doi:10.1086/313440.
  • Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178–182. DOI:10.3201/eid0702.010204.
  • Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–532. doi:10.1056/NEJM199808203390806.
  • Koeck M, Como-Sabetti K, Boxrud D, et al. Burdens of invasive methicillin-susceptible and methicillin-resistant Staphylococcus aureus disease, minnesota, USA. Emerg Infect Dis. 2019;25:171–174. DOI:10.3201/eid2501.181146.
  • Chabot MR, Stefan MS, Friderici J, et al. Reappearance and treatment of penicillin-susceptible Staphylococcus aureus in a tertiary medical centre. J Antimicrob Chemother. 2015;70:3353–3356. DOI:10.1093/jac/dkv270.
  • Richter SS, Doern GV, Heilmann KP, et al. Detection and prevalence of penicillin-susceptible Staphylococcus aureus in the United States in 2013. J Clin Microbiol. 2016;54:812–814. DOI:10.1128/jcm.03109-15.
  • Henderson A, Harris P, Hartel G, et al. Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study. Int J Antimicrob Agents. 2019;54:491–495. DOI:10.1016/j.ijantimicag.2019.05.020.
  • Nissen JL, Skov R, Knudsen JD, et al. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis. J Antimicrob Chemother. 2013;68:1894–1900. DOI:10.1093/jac/dkt108.
  • Butler-Laporte G, Lee TC, Cheng MP. Increasing rates of penicillin sensitivity in Staphylococcus aureus. Antimicrob Agents Chemother. 2018;62; doi:10.1128/AAC.00680-18.
  • Chen S, Zhou Y, Chen Y, et al.. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884–i890. DOI:10.1093/bioinformatics/bty560.
  • Prjibelski A, Antipov D, Meleshko D, et al. Using SPAdes De novo assembler. Curr Protoc Bioinformatics. 2020;70:e102), DOI:10.1002/cpbi.102.
  • Bortolaia V, Kaas RS, Ruppe E, et al. Resfinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020;75:3491–3500. DOI:10.1093/jac/dkaa345.
  • Zankari E, Allesøe R, Joensen KG, et al. Pointfinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72:2764–2768. DOI:10.1093/jac/dkx217.
  • Carvajal LP, Rincon S, Echeverri AM, et al. Novel insights into the classification of staphylococcal β-lactamases in Relation to the Cefazolin Inoculum effect. Antimicrob Agents Chemother. 2020;64; DOI:10.1128/aac.02511-19.
  • Page AJ, Cummins CA, Hunt M, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31:3691–3693. DOI:10.1093/bioinformatics/btv421.
  • Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30:1312–1313.
  • Yu G. Using ggtree to visualize data on tree-like structures. Curr Protoc Bioinformatics. 2020;69:e96), DOI:10.1002/cpbi.96.
  • Jin Y, Yu X, Chen Y, et al. Characterization of highly virulent community-associated methicillin-resistant Staphylococcus aureus ST9-SCCmec XII causing bloodstream infection in China. Emerg Microbes Infect. 2020;9:2526–2535. doi:10.1080/22221751.2020.1848354.
  • Vandendriessche S, Kadlec K, Schwarz S, et al. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals. J Antimicrob Chemother. 2011;66:2455–2459. DOI:10.1093/jac/dkr348.
  • Tavares A, Faria NA, de Lencastre H, et al. Population structure of methicillin-susceptible Staphylococcus aureus (MSSA) in Portugal over a 19-year period (1992-2011). Eur. J. Clin. Microbiol. Infect. Dis. 2014;33:423–432. DOI:10.1007/s10096-013-1972-z.
  • Jin Y, Zhou W, Zhan Q, et al. Genomic epidemiology and Characterization of methicillin-resistant Staphylococcus aureus from bloodstream infections in China. mSystems. 2021;6:e0083721, DOI:10.1128/mSystems.00837-21.
  • Chen L, Chavda KD, Solanki M, et al. Genetic variation among Panton-Valentine leukocidin-encoding bacteriophages in Staphylococcus aureus clonal complex 30 strains. J Clin Microbiol. 2013;51:914–919. DOI:10.1128/jcm.03015-12.
  • Zhao C, Liu Y, Zhao M, et al. Characterization of community acquired Staphylococcus aureus associated with skin and soft tissue infection in Beijing: high prevalence of PVL+ ST398. PloS one. 2012;7:e38577), DOI:10.1371/journal.pone.0038577.
  • Baines SL, Holt KE, Schultz MB, et al. Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus. mBio. 2015;6:e00080), DOI:10.1128/mBio.00080-15.
  • Harris SR, Feil EJ, Holden MT, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science (New York, N.Y.). 2010;327:469–474. DOI:10.1126/science.1182395.
  • Mama OM, Aspiroz C, Lozano C, et al. Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 spanish hospitals. J Antimicrob Chemother. 2021;76:2519–2527. DOI:10.1093/jac/dkab208.
  • Li X, Fang F, Zhao J, et al. Molecular characteristics and virulence gene profiles of Staphylococcus aureus causing bloodstream infection. Braz J Infect Dis. 2018;22:487–494. DOI:10.1016/j.bjid.2018.12.001.
  • Ai X, Gao F, Yao S, et al. Prevalence, characterization, and drug resistance of Staphylococcus aureus in feces from pediatric patients in guangzhou, China. Front Med (Lausanne) 2020. 7. 127. DOI:10.3389/fmed.2020.00127
  • Dong Q, Liu Y, Li W, et al. Phenotypic and molecular characteristics of community-associated Staphylococcus aureus infection in neonates. Infect Drug Resist. 2020;13:4589–4600. DOI:10.2147/idr.S284781.
  • Smith TC, Wardyn SE. Human infections with Staphylococcus aureus CC398. Curr Environ Health Rep. 2015;2:41–51. DOI:10.1007/s40572-014-0034-8.
  • Resman F, Thegerström J, Månsson F, et al. The prevalence, population structure and screening test specificity of penicillin-susceptible Staphylococcus aureus bacteremia isolates in malmö, Sweden. J Infect. 2016;73:129–135. DOI:10.1016/j.jinf.2016.05.011.
  • Price LB, Stegger M, Hasman H, et al. Staphylococcus aureus CC398: host adaptation and emergence of methicillin resistance in livestock. mBio. 2012;3; DOI:10.1128/mBio.00305-11.
  • Uhlemann AC, Porcella SF, Trivedi S, et al. Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. mBio. 2012;3; DOI:10.1128/mBio.00027-12.
  • He L, Zheng HX, Wang Y, et al. Detection and analysis of methicillin-resistant human-adapted sequence type 398 allows insight into community-associated methicillin-resistant Staphylococcus aureus evolution. Genome Med 2018. 10. 5. DOI:10.1186/s13073-018-0514-9
  • Ba XL, Harrison EM, Lovering AL, et al. Old drugs To treat resistant bugs: methicillin-resistant Staphylococcus aureus isolates with mecC Are susceptible to a combination of penicillin and clavulanic acid. Antimicrob Agents Chemother. 2015;59(12):7396–7404. DOI:10.1128/aac.01469-15.
  • Miller WR, Seas C, Carvajal LP, et al. The cefazolin Inoculum Effect Is associated With increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia. Open Forum Infect Dis. 2018;5:ofy123, DOI:10.1093/ofid/ofy123.
  • Lee S, Song KH, Jung SI, et al. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in korea. Clin Microbiol Infect. 2018;24:152–158. DOI:10.1016/j.cmi.2017.07.001.